Publisher excerpt· Laws & Government
FTC and seven states seek contempt ruling against Shkreli over pharma ban
Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in…
This page contains a short attributed excerpt, not a full report. For details and context, see the original source below.
Source attribution
- The Guardian USMaya Yang
Original source links
- The Guardian US: Original source